Perspective Therapeutics (CATX) Debt Ratio (2023 - 2026)

Perspective Therapeutics recorded quarterly Debt Ratio of 0.0 in Q1 2026, down 35.63% quarter-over-quarter from 0.01 in Q4 2025, and down 22.66% year-over-year from 0.0 in Q1 2025.

Perspective Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.0 for Q1 2026.

  • In Q1 2026, Debt Ratio fell 22.66% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (down 22.66% YoY), while the FY2025 annual figure was 0.01, up 23.36% from the prior year.
  • Debt Ratio came in at 0.0 for Q1 2026 at Perspective Therapeutics, down from 0.01 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.02 in Q4 2023 to a low of 0.0 in Q1 2026.
  • A 4-year average of 0.01 and a median of 0.01 in 2025 frame the typical range for Debt Ratio.
  • Across the five-year window, Debt Ratio slumped 72.6% in 2024 and advanced 28.22% in 2025, its largest moves.
  • Perspective Therapeutics' Debt Ratio stood at 0.02 in 2023, then slumped by 72.17% to 0.0 in 2024, then advanced by 23.36% to 0.01 in 2025, then slumped by 35.63% to 0.0 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.01, and 0.01 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.31
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.32
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.31
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.04
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.25
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.27
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.18
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - 0.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.01
Dec 31, 2023 0.02
Sep 30, 2023 0.02
Jun 30, 2023 0.01
Mar 31, 2023 0.01